Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses. by Gottschalk, R, Hathorn, M, Beuneu, H, Corse, E, Dustin, M, Altan-Bonnet, G, Allison, J

Cardiac Safety of Fingolimod 0.5 mg during the First Dose Observation in 4-Month, Open-Label, Multi-Center FIRST Study in Patients with Relapsing MS by Comi, G, Kappos, L, Palace, J, Gottschalk, R, Bijarnia, M, Keil, A, Tomic, D, von Rosenstiel, P, Gold, R

Erratum: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: A phase 3b, open-label study (Journal of Neuro... by Gold, R, Comi, G, Palace, J, Siever, A, Gottschalk, R, Bijarnia, M, Von Rosenstiel, P, Tomic, D, Kappos, L

Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study. by Gold, R, Comi, G, Palace, J, Siever, A, Gottschalk, R, Bijarnia, M, von Rosenstiel, P, Tomic, D, Kappos, L

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: A phase 3b, open-label study by Gold, R, Comi, G, Palace, J, Siever, A, Gottschalk, R, Bijarnia, M, Von Rosenstiel, P, Tomic, D, Kappos, L

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study. by Gold, R, Comi, G, Palace, J, Siever, A, Gottschalk, R, Bijarnia, M, von Rosenstiel, P, Tomic, D, Kappos, L

Cardiac safety of fingolimod 0.5 mg during the first-dose observation in a 4-month, open-label, multicentre FIRST study in relapsing multiple sclerosis patients by Gold, R, Kappos, L, Palace, J, Siever, A, Marrosu, M, Gottschalk, R, Bijarnia, M, Keil, A, Tomic, D, von Rosenstiel, P, Comi, G

Safety and tolerability of fingolimod 0.5 mg during the first 4 months of administration in patients with relapsing forms of multiple sclerosis. Results from the open-label, multic... by Kappos, L, Comi, G, Palace, J, Siever, A, Marrosu, M, Mehling, M, Gottschalk, R, Bijarnia, M, Keil, A, Tomic, D, von Rosenstiel, P, Gold, R

Highly infectious diseases in the Mediterranean Sea area: Inventory of isolation capabilities and recommendations for appropriate isolation by Carson, G, Fusco, FM, Brouqui, P, Ippolito, G, Vetter, N, Kojouharova, M, Parmakova, K, Skinhoej, P, Siikamaki, H, Perronne, C, Schilling, S, Gottschalk, R, Brodt, HR, Maltezou, HC, Adrami, O, Lambert, J, Puro, V, De Iaco, G, Hemmer, R, Borg, M, Fjellet, AL, Brantsæter, AB, Horban, A, Strle, F, Trilla, A, Bannister, B